Rank #1362MYGN

Myriad Genetics, Inc.

$4.38

0.23% (Daily)

Market Cap

$408.28M

Revenue

$825.30M

Rank by MCap

#1362

Sector

Healthcare

Industry

Diagnostics & Research

CEO

Mr. Samraat S. Raha

Headquarters

Salt Lake City, UT

Employees

2,700

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test to help determine the therapy for metastatic breast, ovarian, metastatic pancreat...